---
title: 'Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell
  lymphomas: a phase 1b/2a trial'
date: '2024-11-15'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39548313/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&fc=20220923065203&ff=20241116183742&v=2.18.0.post9+e462414
source: (((leukemia) OR (lymphoma)) OR (myeloma)) AND (Stanford University[Affiliation])
description: No ...
disable_comments: true
---
No ...